Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
Barisic S, Brahmbhatt EM, Cherkasova E, Spear TT, Savani U, Pierre S, Scurti GM, Chen L, Igboko M, Nadal R, Zeng G, Parry G, Stroncek DF, Highfill S, Dalheim AV, Reger R, Nishimura MI, Childs RW.
Barisic S, et al.
J Immunother Cancer. 2024 Sep 11;12(9):e009147. doi: 10.1136/jitc-2024-009147.
J Immunother Cancer. 2024.
PMID: 39266213
Free PMC article.